Skip to main content
Equibles
CPRX logo

CPRX · Catalyst Pharmaceuticals, Inc.

Track CPRX — free

Use CPRX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about CPRX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
Market Cap
$3.85B
Shares
122.38M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-06-30 Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses
2026-05-11 Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results
2026-05-07 Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast
2026-05-07 Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
2026-05-07 Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.
2026-04-28 Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026
2026-03-06 Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference
2026-02-25 Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance
2026-02-24 Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference
2026-02-11 Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026
2026-01-08 Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies

Past events

Date Event Type
2026-05-12 Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026 Earnings call
2026-03-10 Barclays 28th Annual Global Healthcare Conference Conference
2026-02-26 Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026 Earnings call
2026-02-26 Catalyst Pharmaceuticals Fourth Quarter and Full-Year 2025 Financial Results Event
2026-01-12 44th Annual J.P. Morgan Healthcare Conference Presentation Conference
2025-12-08 Bank of America CNS Therapeutics Virtual Conference Conference
2025-12-02 Citi's 2025 Global Healthcare Conference Conference
2025-11-17 Jefferies Global Healthcare Conference Presentation Conference
2025-11-06 Catalyst Pharmaceuticals Third Quarter 2025 Financial Results Event

Source: https://ir.catalystpharma.com/overview/default.aspx

Key facts CIK 1369568 CUSIP 14888U101 13F (30d) 352 filings 350 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)